Interaction between glutamatergic-NMDA and cholinergic-muscarinic systems in classical fear conditioning

Brain Research Bulletin

Volumn 77, Issue 2-3, 2008, Pages 71-76

  Figueredo, Larissa Zeggio Perez ^a   Moreira, Karin Monteiro ^a   Ferreira, Tatiana Lima ^a   Fornari, Raquel Vecchio ^a   Oliveira, Maria Gabriela Menezes ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Dicyclomine; Hippocampus; Learning and memory; M1receptor; MK 801

Indexed keywords

DICYCLOVERINE; DIZOCILPINE; GLUTAMIC ACID; MUSCARINIC AGENT; MUSCARINIC M1 RECEPTOR; N METHYL DEXTRO ASPARTIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC SYSTEM; CONDITIONED REFLEX; CONTROLLED STUDY; DOSE RESPONSE; FREEZING; HIPPOCAMPUS; LEARNING; MALE; MEMORY; MOLECULAR INTERACTION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; TASK PERFORMANCE;

ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING, CLASSICAL; DICYCLOMINE; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; FEAR; GLUTAMIC ACID; HIPPOCAMPUS; MALE; MUSCARINIC ANTAGONISTS; N-METHYLASPARTATE; RATS; RATS, WISTAR; RECEPTOR, MUSCARINIC M1; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 51749083458     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2008.05.008     Document Type: Article

References (49)

1. Anagnostaras S.G., Maren S., and Fanselow M.S. Scopolamine selectively disrupts the acquisition of contextual fear conditioning in rats. Neurobiol. Learn. Mem. 64 (1995) 191-194
2. Anagnostaras S.G., Maren S., Sage J.R., Goodrish S., and Fanselow M.S. Scopolamine and pavlovian fear conditioning in rats: dose-effect analysis. Neuropsychopharmacology 21 (1999) 731-744
3. Anagnostaras S.G., Murphy G.G., Hamilton S.E., Mitchell S.L., Rahnama N.P., Nathanson N.M., and Silva A.J. Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice. Nat. Neurosci. 6 (2003) 51-58
4. Bartus R.T., Dean R.L., Beer B., and Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science 217 (1982) 408-417
5. Bast T., Zhang W.N., and Feldon J. Dorsal hippocampus and classical fear conditioning to tone and context in rats: effects of local NMDA-receptor blockade and stimulation. Hippocampus 13 (2003) 657-675
6. Bouton M.E., and Bolles R.C. Conditioned fear assessed by freezing and by the suppression of three different baselines. Anim. Learn. Behav. 8 (1980) 429-434
7. Brosnan-Watters G., Wozniak D.F., Nardi A., and Olney J.W. Acute behavioral effects of MK-801 in the mouse. Pharmacol. Biochem. Behav. 53 (1996) 701-711
8. Castellano C., Cestari V., and Ciamei A. NMDA receptors and learning and memory processes. Curr. Drug Targets 2 (2001) 273-283
9. Doods H.N., Mathy M.J., Davidesko D., van Charldorp K.J., de Jorge A., and Zwieten P.A. Selectivity of muscarinic antagonists in radioligand and in vivo experiments for the putative M1, M2 and M3 receptors. J. Pharmacol. Exp. Ther. 242 (1987) 257-262
10. Eglen R.M., and Watson N. Selective muscarinic receptor agonists and antagonists. Pharmacol. Toxicol. 78 (1996) 59-68
11. Elrod K., and Buccafusco J.J. An evaluation of the mechanism of scopolamine-induced impairment in two passive avoidance protocols. Pharmacol. Biochem. Behav. 29 (1998) 15-21
12. Fendt M., and Fanselow M.S. The neuroanatomical and neurochemical basis of conditioned fear. Neurosci. Biobehav. 23 (1999) 743-760
13. Ferreira T.L., Moreira K.M., Ikeda D.C., Bueno O.F., and Oliveira M.G. Effects of dorsal striatum lesions in tone fear conditioning and contextual fear conditioning. Brain Res. 987 (2003) 17-24
14. Fibiger H.C., Damsma G., and Day J.C. Behavioral pharmacology and biochemistry of central cholinergic neurotransmission. Adv. Exp. Med. Biol. 295 (1991) 399-414
15. Fornari R.V., Moreira K.M., and Oliveira M.G.M. Effects of the selective M1 muscarinic receptor antagonist dicyclomine on emotional memory. Learn Mem. 7 (2000) 287-292
16. Giachetti A., Giraldo E., Ladinsky H., and Montagna E. Binding and functional profiles of the selective M1 muscarinic receptor antagonists trihexyphenidyl and dicyclomine. Br. J. Pharmacol. 89 (1986) 83-90
17. Gould T.J., McCarthy M.M., and Keith R.A. MK-801 disrupts acquisition of contextual fear conditioning but enhances memory consolidation of cued fear conditioning. Behav. Pharmacol. 24 (2002) 287-294
18. Harrod S.B., Flint R.W., and Riccio D.C. MK-801 induced retrieval, but not acquisition, deficits for passive avoidance conditioning. Pharmacol. Biochem. Behav. 69 (2001) 585-593
19. Heale V., and Harley C. MK-801 and AP5 impair acquisition, but not retention, of the Morris milk maze. Pharmacol. Biochem. Behav. 36 (1990) 145-149
20. Hlinak Z., and Krejci I. Concurrent administration of subeffective doses of scopolamine and MK-801 produces a short-term amnesia for the elevated plus-maze in mice. Behav. Brain Res. 91 (1998) 83-89
21. Hlinak Z., and Krejci I. MK-801 induced amnesia for the elevated plus-maze in mice. Behav. Brain Res. 131 (2002) 221-225
22. Hunter A.J., and Roberts F.F. The effect of pirenzepine on spatial learning in the Morris water maze. Pharmacol. Biochem. Behav. 30 (1987) 519-523
23. Kim J.J., and Fanselow M.S. Modality-specific retrograde amnesia of fear. Science 256 (1992) 675-677
24. Ledoux J.E. Emotional memory systems in the brain. Behav. Brain Res. 58 (1993) 69-79
25. Li H.B., Matsumoto K., Tohda M., Yamamoto M., and Watanabe H. NMDA antagonists potentiate scopolamine-induced amnesic effect. Behav. Brain Res. 83 (1997) 225-228
26. Liu W., Kumar A., and Alreja M. Excitatory effects of muscarine on septohippocampal neurons: involvement of M3 receptors. Brain Res. 805 (1998) 220-233
27. Malenka R.C., and Nicoll R.A. Long term potentiation - a decade of progress?. Science 285 (1999) 1870-1874
28. Markram H., and Segal M. Long-lasting facilitation of excitatory postsynaptic potentials in the rat hippocampus by acetylcholine. J. Physiol. 427 (1990) 381-393
29. Miyakawa T., Yamada M., Duttaroy A., and Wess J. Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor. J. Nat. Neurosci. 21 (2001) 5239-5250
30. Mondadori C., Weiskrantz L., Buerki H., Petschke F., and Fagg G.E. NMDA receptor antagonists can enhance or impair learning performance in animals. Exp. Brain Res. 75 (1989) 449-456
31. Moreira K.M., Ferreira T.L., Fornari R.V., Figueredo L.Z.P., and Oliveira M.G.M. Interaction between M1-muscarinic and glutamatergic NMDA receptors on an inhibitory avoidance task. Brain Res. Bull. 67 (2005) 504-508
32. Muñoz C., and Grossman S.P. Spatial discrimination, reversal and active or passive avoidance learning in rats with KA-induced neuronal depletions in dorsal hippocampus. Brain Res. Bull. 6 (1981) 399-406
33. Ohno M., and Watanabe S. Interactive processing between glutamatergic and cholinergic systems involved in inhibitory avoidance learning of rats. Eur. J. Pharmacol. 312 (1996) 145-147
34. Oliveira M.G.M., Bueno O.F., Pomarico A.C., and Gugliano E.B. Strategies used by hippocampal- and caudate-putamen-lesioned rats in a learning task. Neurobiol. Learn. Mem. 68 (1997) 32-41
35. Packard M.G., and Teather A.L. Posttraining injections of MK-801 produce a time-dependent impairment of memory in two water maze tasks. Neurobiol. Learn. Mem. 68 (1997) 42-50
36. Parada-Turska J., and Turski W.A. Excitatory amino acid antagonists and memory: effect of drugs acting at N-methyl-d-aspartate receptors in learning and memory tasks. Neuropharmacology 29 (1999) 1111-1116
37. Phillips R.G., and LeDoux J.E. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav. Neurosci. 106 (1992) 274-285
38. Quirarte G.L., Cruz-Morales S.E., Cepeda A., Garcia-Montanez M., Roldan-Roldan G., and Prado-Alcala R.A. Effects of central muscarinic blockade on passive avoidance: anterograde amnesia, state dependency, or both?. Behav. Neural. Biol. 62 (1994) 15-20
39. Rouse S.T., Marino M.J., Potter L.T., Conn P.J., and Levey A.I. Muscarinic receptor subtypes involved in hippocampal circuits. Life Sci. 64 (1999) 501-509
40. Rudy J.W. Scopolamine administered before and after training impairs both contextual and auditory-cue fear conditioning. Neurobiol. Learn. Mem. 65 (1996) 73-81
41. Sala M., Braida D., Calcaterra P., Leone M.P., Comotti F.A., Gianola S., and Gori E. Effect of centrally administered atropine and pirenzepine on radial arm maze performance in the rat. Eur. J. Pharmacol. 194 (1991) 45-49
42. Schenberg E.E., Soares J.C., and Oliveira M.G.M. Effects of pre- or post-training entorhinal cortex AP5 injection on fear conditioning. Physiol. Behav. 86 (2005) 508-515
43. Sen A.P., and Bhattacharya S.K. Effect of selective muscarinic receptor agonists and antagonists on active-avoidance learning acquisition in rats. Indian J. Exp. Biol. 29 (1991) 136-139
44. Solana-Figueroa R., Salgado-Castillo R., Quirarte G.L., Galindo L.E., and Prado-Alcalá R.A. Enhanced Inhibitory avoidance training protects against the amnesic effect of p-chloroamphetamine. Life Sci. 71 (2002) 391-399
45. Tinsley M.R., Quinn J.J., and Fanselow M.S. The role of muscarinic and nicotinic cholinergic neurotransmission in aversive conditioning: comparing pavlovian fear conditioning and inhibitory avoidance. Learn. Mem. 11 (2004) 35-42
46. Wallenstein G.V., and Vago D.R. Intrahippocampal scopolamine impairs both acquisition and consolidation of contextual fear conditioning. Neurobiol. Learn. Mem. 75 (2001) 245-252
47. Ward L., Mason S.E., and Abraham W.C. Effects of the NMDA antagonists CPP and MK-801 on radial arm maze performance in rats. Pharmacol. Biochem. Behav. 35 (1990) 785-790
48. White A.M., and Best P.J. The effects of MK-801 on spatial working memory and within-session spatial learning. Pharmacol. Biochem. Behav. 59 (1998) 613-617
49. Young S.L., Bohenek D.L., and Fanselow M.S. Scopolamine impairs acquisition and facilitates consolidation of fear conditioning: differential effects for tone vs context conditioning. Neurobiol. Learn. Mem. 63 (1995) 174-180